Home |  MDD | AIMDD | IVDD | Italian Registrations | Consulting & Support Services | About MDSS | Contact MDSS | Client Login                                                   

Home
About MDSS
Newsletters
MDD
IVDD
AIMDD
Italian Product Registrations
Consulting & Support Services
Events
WWW Links
Contact MDSS

 

MDSS
serves clients' specific needs with changes
of products and regulations.  Each client is unique and MDSS customizes the solution for each client individually.

 

 
The Importance of Being Authorized

The Importance of Being Authorized*
Dr. Maria E. Donawa

ABSTRACT

MDD 93/42/EEC stipulates most clearly, the necessity for appointing an ‘Authorized Representative’. (Article 14.2, Annex 1 - essential requirements and Annex VII - EC Declaration of Conformity). The Author discusses the concept behind appointing an ‘Authorized Representative’ and what the medical device manufacturer MUST bear in mind, BEFORE announcing such an appointment.

The article discusses the role of the authorized representative, as specified in the published Directives and as defined in the proposed European Directive on in vitro diagnostic medical devices.

- "Medical device companies located outside the European Economic Area(EEA) and without subsidiaries in the EEA, will need to designate authorized representatives to perform certain duties under the European medical device Directives. The duties and responsibilities of those representatives, should be clearly understood by medical device companies and prospective authorized representatives BEFORE any designation contract is signed".

- "it is clear, that manufacturers designating authorized representatives, should do so in writing and carefully define all assigned duties and responsibilities. Also, it is important to distinguish between the regulatory role of the authorized representative and the role of persons or entities responsible for marketing or importing devices into the EEA".

- "the manufacturer may instruct his authorized representative established in the Community, to initiate the procedures for EC Type-Examination, EC Verification, EC Declaration of Conformity (Class I and Class IIa devices)."

- "…the Competent Authorities in charge of market surveillance must be able, particularly in emergencies, to contact the manufacturer or his authorized representative established in the Community…".

- "the label, or the outer packaging, or instructions for use, shall contain in addition the name and address of either the person responsible referred to in Article 14(2) or of the authorized representative of the manufacturer established within the Community".

- "Manufacturers should be careful to designate only those authorized representatives who are qualified to represent the manufacturer’s interests in the EEA with regard to the Directives. That is, authorized representatives need to be able to effectively carry out the procedures that they are designated to carry out and to understand the regulatory significance of representing the manufacturer to Competent Authorities and/or Notified Bodies. Also, manufacturers should maintain copies of all relevant documents and correspondence, so that they are fully aware of their compliance with the Directives at all times".

©copyright April 1996, Medical Device Technology, by: Maria E. Donowa


*To receive a hard copy of the original article, 
click on the 'Send Article' link for an e-mail request form.

Send article

Return To Previous Page

       
 

Home |  MDD | AIMDD | IVDD | Italian Registrations | Consulting & Support Services | About MDSS | Contact MDSS | Client Login                                                   

 
 

©Medical Device Safety Service, GmbH